Please use this identifier to cite or link to this item:
|Title: ||Computer aided drug discovery: Design, synthesis and testing of novel anti-cancer agents|
|Authors: ||Wassef, Abram|
|Issue Date: ||31-Mar-2015|
|Publisher: ||University of Sydney|
Faculty of Pharmacy
|Abstract: ||The continuous enhancements of computational tools for drug discovery, have greatly improved the pre-clinical stages of pharmaceutical research, to a higher level of efficiency and greater speed. The combination between homology modelling methods in structure-based drug design, and the chemoinformatics techniques in lead optimization, has allowed successful development of small molecule inhibitors with 30 folds higher potency of best known ASCT2 inhibitors.
Three dimensional model of ASCT2 protein was constructed via fold recognition technique, the preferred method in absence of highly similar protein sequences. This model was used in virtual screening against commercial SPECs database comprised of approximately 300 000 compounds of drug-like molecules to identify potential inhibitors and characterize active site interactions through different docking procedures. Visual analysis of the docking poses with correlation to the biological results has allowed verification of the ASCT2 active site and determine the important residues for strong ligand binding. Furthermore, the ASCT2 model has been used to validate the biological results of the lead development stage through further docking analysis.
AMACR homology model was built using the three dimensional X-ray crystal structure of MCR with high sequence similarity and shared protein family. The Maestro modelling software platform offered highly accurate model predictions and further docking calculations in the virtual screening stage. The biological testing was highly reliant on general cell viability results rather than specific AMACR inhibition due to the high cost and difficulties associated with AMACR activity assays.
To conclude, computer-aided drug discovery in partnership with complementary in vitro techniques have made major contributions in this thesis, to develop biologically active molecules, demonstrating the high efficiency, great speed and cost-effective advantages of molecular modelling.|
|Access Level: ||Access is restricted to staff and students of the University of Sydney . UniKey credentials are required. Non university access may be obtained by visiting the University of Sydney Library.|
|Rights and Permissions: ||The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.|
|Type of Work: ||PhD Doctorate|
|Type of Publication: ||Doctor of Philosophy Ph.D.|
|Appears in Collections:||Sydney Digital Theses (University of Sydney Access only)|
This work is protected by Copyright. All rights reserved. Access to this work is provided for the purposes of personal research and study. Except where permitted under the Copyright Act 1968, this work must not be copied or communicated to others without the express permission of the copyright owner. Use the persistent URI in this record to enable others to access this work.
|WASSEF Abram - Final Thesis.pdf||Final Thesis||3.04 MB||Adobe PDF|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.